Transcatheter aortic valve implantation (TAVI) has risen over the past 20 years as a safe and
effective alternative to surgical aortic valve replacement for treatment of severe aortic …

Abstract Background/Aim With the growing contemporary use of bioprosthetic valves, whose
limited long‐term durability has been well‐documented, an increase in the need for …

Objectives The aim of this study was to examine real-world experience with repeat
transcatheter aortic valve replacement (TAVR) in a population-based national database …

Objective There is an increasing amount of evidence supporting use of transcatheter aortic
valve replacement (TAVR) for treatment of aortic stenosis in patients at low or intermediate …

ABSTRACT Introduction The Inspiris Resilia tissue valve was recently introduced into
clinical practice. This review summarizes the pre-clinical and clinical studies leading to this …

Introduction Currently, several balloon-expandable (BE) and self-expanding (SE)
transcatheter aortic valves (TAVs) are available in clinical practice. Each of them has …

Background Surgical aortic valve bioprostheses may degenerate over time and require redo
intervention. Transcatheter aortic valve replacement (TAVR) is a less invasive alternative to …

Transcatheter heart valve technology has rapidly progressed since initial approval in the
United States. There are currently two widely available transcatheter heart valve delivery …

Objective Surgical aortic valve replacement (SAVR) is traditionally the gold-standard
treatment in patients with aortic valve disease. The advancement of transcatheter aortic …

Bioprosthetic valves are increasingly being used to treat young patients needing surgical
intervention. The rising number of young patients undergoing bioprosthesis implantation …